3Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol, 1971, 231:232 - 235.
4Crofford LJ. COX-1 and COX-2 tissue expression: implications and predictions. J Rheumatol, 1997, 24:15 - 19.
5Chandrasekharan NV, Dai H, Roos KL, et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA, 2002, 99:13926 - 13931.
6Baigeut C , Patron C. Selective cyclooxygenase-2 inhibitors, aspirin,and cardiovascular disease. Arthritis & Rheum, 2003, 48 : 12 - 20.
7Smith TJ. Cyclooxygenases as the principal targets for the actions of NSAIDs. Rheum Dis Clin North Am,1998, 24:501.
8Mamdani M, Rochon PA, Juurlink DN, et al. Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal antiinflammatory drugs. BMJ, 2002, 325:624 - 627.
9DeKosky ST. Similar enzymes, different mechanisms: COX-1 and COX-2 enzymes in neurologic disease. Arch Neurol, 2003, 60:632 -633.
